The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.
Rahman, A., Korzekwa, K., Grogan, J., Gonzalez, F. J., & Harris, J. W. (1994) · PubMed · Cited by 430
McTaggart, F., Buckett, L., Davidson, R., Holdgate, G., McCormick, A., Schneck, D., Smith, G., & Warwick, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01454-0 · Cited by 413
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
Prueksaritanont, T., Subramanian, R., Fang, X., Ma, B., Qiu, Y., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.505 · Cited by 344
Self-citationMechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
Prueksaritanont, T., Zhao, J. J., Ma, B., Roadcap, B. A., Tang, C., Qiu, Y., Liu, L., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1042 · Cited by 287
Self-citation(1997) · PubMed · Cited by 271
Plasma concentrations of active simvastatin acid are increased by gemfibrozil
Backman, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108507 · Cited by 264
Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
Miller, D. B., & Spence, J. D. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00003 · Cited by 259
Jacobsen, W., Kuhn, B., Soldner, A., Kirchner, G., Sewing, K.-F., Kollman, P. A., Benet, L. Z., & Christians, U. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15086-6 · Cited by 236
In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
Soars, M. G., Burchell, B., & Riley, R. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.382 · Cited by 228
Kyrklund, C., Backman, J. T., Kivistö, K. T., Neuvonen, M., Laitila, J., & Neuvonen, P. J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115542 · Cited by 191
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen, X., Wang, J. S., Backman, J. T., Kivistö, K. T., & Neuvonen, P. J. (2001) · PubMed · Cited by 139
Clinical Pharmacokinetics of Cerivastatin
ck, W. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00002 · Cited by 135
Learning from the cerivastatin experience
Farmer, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06489-3 · Cited by 105
Prueksaritanont, T., Ma, B., Tang, C., Meng, Y., Assang, C., Lü, P., Reider, P. J., Lin, J. H., & Baillie, T. A. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00903.x · Cited by 102
Self-citationBoberg, M., Angerbauer, R., Fey, P., Kanhai, W. K., Karl, W., Kern, A., Ploschke, J., & Radtke, M. (1997) · PubMed · Cited by 77
Murdock, D. K., Murdock, A. K., Murdock, R., Olson, K. J., Frane, A. M., Kersten, M., Joyce, D. M., & Gantner, S. E. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70261-9 · Cited by 75
Inhibitors of fatty acid oxidation
Schulz, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90375-4 · Cited by 61
Rosuvastatin is a high affinity substrate of hepatic organic anion transporter OATP-C
Brown, C., Windass, A. S., Bleasby, K., & Lauffart, B. (2001) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)80225-7 · Cited by 60
Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
Boberg, M., Angerbauer, R., Kanhai, W. K., Karl, W., Kern, A., Radtke, M., & Steinke, W. (1998) · PubMed · Cited by 45
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Metabolic disposition of simvastatin in patients with T-tube drainage.
Cheng, H., Schwartz, M. S., Vickers, S., Gilbert, J. D., Amin, R. D., Depuy, B., Liu, L., Rogers, J. D., Pond, S. M., & Duncan, C. A. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08287-x · Cited by 38
beta-Oxidation of simvastatin in mouse liver preparations.
Prueksaritanont, T., Ma, B., Fang, X., Subramanian, R., Yu, J., & Lin, J. H. (2001) · PubMed · Cited by 37
Self-citationThe fibrates in clinical practice: Focus on micronised fenofibrate
Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)05380-2 · Cited by 34
Rašlová, K., Dubovská, D., Mongiellová, V., & Trnovec, T. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050257 · Cited by 17
Cited by
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875
Metadata
- Authors
- Prueksaritanont, T., Tang, C., Qiu, Y., Mu, L., Subramanian, R., & Lin, J. H.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 30
- Issue
- 11
- Pages
- 1280-1287
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2028211844
- Cited by
- 325
- References
- 25
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.